J Otten1, C Mellberg1, M Ryberg1, S Sandberg1, J Kullberg2, B Lindahl1, C Larsson3, J Hauksson4, T Olsson1. 1. Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden. 2. Department of Radiology, Uppsala University, Uppsala, Sweden. 3. Department of Food and Nutrition, and Sport Science, University of Gothenburg, Gothenburg, Sweden. 4. Center for Medical Technology and Radiation Physics, Umeå University Hospital, Umeå, Sweden.
Abstract
BACKGROUND/ OBJECTIVES: Our objective was to investigate changes in liver fat and insulin sensitivity during a 2-year diet intervention. An ad libitum Paleolithic diet (PD) was compared with a conventional low-fat diet (LFD). SUBJECTS/ METHODS:Seventy healthy, obese, postmenopausal women were randomized to either a PD or a conventional LFD. Diet intakes were ad libitum. Liver fat was measured with proton magnetic resonance spectroscopy. Insulin sensitivity was evaluated with oral glucose tolerance tests and calculated as homeostasis model assessment-insulin resistance (HOMA-IR)/liver insulin resistance (Liver IR) index for hepatic insulin sensitivity and oral glucose insulin sensitivity (OGIS)/Matsuda for peripheral insulin sensitivity. All measurements were performed at 0, 6 and 24 months. Forty-one women completed the examinations for liver fat and were included. RESULTS:Liver fat decreased after 6 months by 64% (95% confidence interval: 54-74%) in the PD group and by 43% (27-59%) in the LFD group (P<0.01 for difference between groups). After 24 months, liver fat decreased 50% (25-75%) in the PD group and 49% (27-71%) in the LFD group. Weight reduction between baseline and 6 months was correlated to liver fat improvement in the LFD group (rs=0.66, P<0.01) but not in the PD group (rs=0.07, P=0.75). Hepatic insulin sensitivity improved during the first 6 months in the PD group (P<0.001 for Liver IR index and HOMA-IR), but deteriorated between 6 and 24 months without association with liver fat changes. CONCLUSIONS: A PD with ad libitum intake had a significant and persistent effect on liver fat and differed significantly from a conventional LFD at 6 months. This difference may be due to food quality, for example, a higher content of mono- and polyunsaturated fatty acids in the PD. Changes in liver fat did not associate with alterations in insulin sensitivity.
RCT Entities:
BACKGROUND/ OBJECTIVES: Our objective was to investigate changes in liver fat and insulin sensitivity during a 2-year diet intervention. An ad libitum Paleolithic diet (PD) was compared with a conventional low-fat diet (LFD). SUBJECTS/ METHODS: Seventy healthy, obese, postmenopausal women were randomized to either a PD or a conventional LFD. Diet intakes were ad libitum. Liver fat was measured with proton magnetic resonance spectroscopy. Insulin sensitivity was evaluated with oral glucose tolerance tests and calculated as homeostasis model assessment-insulin resistance (HOMA-IR)/liver insulin resistance (Liver IR) index for hepatic insulin sensitivity and oral glucose insulin sensitivity (OGIS)/Matsuda for peripheral insulin sensitivity. All measurements were performed at 0, 6 and 24 months. Forty-one women completed the examinations for liver fat and were included. RESULTS: Liver fat decreased after 6 months by 64% (95% confidence interval: 54-74%) in the PD group and by 43% (27-59%) in the LFD group (P<0.01 for difference between groups). After 24 months, liver fat decreased 50% (25-75%) in the PD group and 49% (27-71%) in the LFD group. Weight reduction between baseline and 6 months was correlated to liver fat improvement in the LFD group (rs=0.66, P<0.01) but not in the PD group (rs=0.07, P=0.75). Hepatic insulin sensitivity improved during the first 6 months in the PD group (P<0.001 for Liver IR index and HOMA-IR), but deteriorated between 6 and 24 months without association with liver fat changes. CONCLUSIONS: A PD with ad libitum intake had a significant and persistent effect on liver fat and differed significantly from a conventional LFD at 6 months. This difference may be due to food quality, for example, a higher content of mono- and polyunsaturated fatty acids in the PD. Changes in liver fat did not associate with alterations in insulin sensitivity.
Authors: Miriam Cnop; Melinda J Landchild; Josep Vidal; Peter J Havel; Negar G Knowles; Darcy R Carr; Feng Wang; Rebecca L Hull; Edward J Boyko; Barbara M Retzlaff; Carolyn E Walden; Robert H Knopp; Steven E Kahn Journal: Diabetes Date: 2002-04 Impact factor: 9.461
Authors: Helen M Parker; Nathan A Johnson; Catriona A Burdon; Jeffrey S Cohn; Helen T O'Connor; Jacob George Journal: J Hepatol Date: 2011-10-21 Impact factor: 25.083
Authors: Fredrik Rosqvist; David Iggman; Joel Kullberg; Jonathan Cedernaes; Hans-Erik Johansson; Anders Larsson; Lars Johansson; Håkan Ahlström; Peter Arner; Ingrid Dahlman; Ulf Risérus Journal: Diabetes Date: 2014-02-18 Impact factor: 9.461
Authors: Lutgarda Bozzetto; Anna Prinster; Giovanni Annuzzi; Lucia Costagliola; Anna Mangione; Alessandra Vitelli; Raffaella Mazzarella; Margaret Longobardo; Marcello Mancini; Carlo Vigorito; Gabriele Riccardi; Angela A Rivellese Journal: Diabetes Care Date: 2012-07 Impact factor: 19.112
Authors: Mary P Moore; Rory P Cunningham; Ryan J Dashek; Justine M Mucinski; R Scott Rector Journal: Obesity (Silver Spring) Date: 2020-09-06 Impact factor: 5.002
Authors: Lee Hooper; Nicole Martin; Oluseyi F Jimoh; Christian Kirk; Eve Foster; Asmaa S Abdelhamid Journal: Cochrane Database Syst Rev Date: 2020-08-21
Authors: Lee Hooper; Nicole Martin; Oluseyi F Jimoh; Christian Kirk; Eve Foster; Asmaa S Abdelhamid Journal: Cochrane Database Syst Rev Date: 2020-05-19
Authors: Rustam N Karanjia; Mary M E Crossey; I Jane Cox; Haddy K S Fye; Ramou Njie; Robert D Goldin; Simon D Taylor-Robinson Journal: World J Gastroenterol Date: 2016-12-07 Impact factor: 5.742
Authors: Julia Otten; Jonas Andersson; Jens Ståhl; Andreas Stomby; Ahmed Saleh; Maria Waling; Mats Ryberg; Jon Hauksson; Michael Svensson; Bengt Johansson; Tommy Olsson Journal: J Am Heart Assoc Date: 2019-01-22 Impact factor: 5.501
Authors: Julia Otten; Andreas Stomby; Maria Waling; Andreas Isaksson; Ingegerd Söderström; Mats Ryberg; Michael Svensson; Jón Hauksson; Tommy Olsson Journal: Diabetologia Date: 2018-04-26 Impact factor: 10.122